Medical News

RSS

Meditrina licensor AstraZeneca granted US allowance of patent for endometriosis treatment

Meditrina Pharmaceuticals, Inc., a clinical-stage, specialty pharmaceutical company focused on developing and commercializing innovative therapies that treat women's reproductive system disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Composition Comprising a Combination of an Aromatase Inhibitor, a Progestin, and an Oestrogen and its Use for the Treatment of Endometriosis" to the Company's licensor AstraZeneca.

10 Sep 2010

SAEC collaborates with Newcastle University for drug induced liver injury research

The International Serious Adverse Events Consortium (SAEC) announced today it will collaborate with Newcastle University to research the genetics of drug induced liver injury.

10 Sep 2010

Overhaul's effect on health spending minimal, government study says

The health overhaul and other recent legislative and regulatory changes will only modestly increase the nation's health tab through 2019, according to a government study published today, Kaiser Health News reports.

10 Sep 2010

Assessing the needs of disabled Medicare beneficiaries

Kaiser Health News staff writer Jessica Marcy reports in this KHN short take: "Policy makers need more concrete information about the characteristics of the disabled community and its unique challenges, a senior White House adviser said today at a forum about Medicare disability and health care reform" (Marcy, 9/9).

10 Sep 2010

Translational Research issue focuses field of stem cell research, therapy

The use of stem cells for research and their possible application in the treatment of disease are hotly debated topics. In a special issue of Translational Research published this month an international group of medical experts presents an in-depth and balanced view of the rapidly evolving field of stem cell research and considers the potential of harnessing stem cells for therapy of human diseases including cardiovascular diseases, renal failure, neurologic disorders, gastrointestinal diseases, pulmonary diseases, neoplastic diseases, and type 1 diabetes mellitus.

10 Sep 2010

PediaWorks, Medikit form PediaCath to develop pediatric catheters

PediaWorks and Medikit Co., Ltd. announced the formation of PediaCath, Inc., a joint venture to help alleviate the severe shortage of medical devices for use in pediatric patients.

10 Sep 2010

Highlights of 23rd Congress of European College of Neuropsychopharmacology 2010

More than 7,000 psychiatrists, neurologists, psychologists and neuroscience researchers from all over the world met at the 23rd Congress of the European College of Neuropsychopharmacology (ECNP) from 28 August to 1 September 2010 in Amsterdam.

10 Sep 2010

Study proves brain imaging data can track aberrant brain development

Five minutes in a scanner can reveal how far a child's brain has come along the path from childhood to maturity and potentially shed light on a range of psychological and developmental disorders, scientists at Washington University School of Medicine in St. Louis have shown.Researchers assert this week in Science that their study proves brain imaging data can offer more extensive help in tracking aberrant brain development.

10 Sep 2010

Gates Foundation 2009 annual report released

The Bill & Melinda Gates Foundation on Tuesday released its 2009 annual report (.pdf) highlighting some of the foundation's work over the last year, the Puget Sound Business Journal reports (Holtzman, 9/7).

10 Sep 2010

Avinger initiates enrollment in Wildcat Catheter trial for chronic total occlusions in femoropopliteal lesions

Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announces the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. The CONNECT trial is a prospective, multi-center, non-randomized study intended to evaluate the Wildcat Catheter's ability to cross chronic total occlusions in femoropopliteal lesions.

10 Sep 2010

Children with severe, therapy-resistant asthma more likely to have poorer lung function: SARP

A subset of children with asthma suffers from severe, treatment-resistant disease associated with more illness and greater allergic hypersensitivity, according to the results of the National Heart, Blood, and Lung Institute's Severe Asthma Research Program, presented in a recently published article in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal published by Mary Ann Liebert, Inc..

10 Sep 2010

Researchers discover generation of pyramidal neurons by glial cell precursors

In an unanticipated finding, researchers at the UC Davis School of Medicine have discovered that, during early adulthood, the brain produces new excitatory neurons, and that these neurons arise from non-neuronal support cells in an area of the brain that processes smell.

10 Sep 2010

Obama administration asks appeals court to lift ban on stem cell research funding

The Obama administration on Wednesday asked an appeals court for an emergency stay that would lift the ban on federal funding of research involving human embryonic stem cells. U.S. District Judge Royce Lamberth last month ruled that the research violated U.S. law because it involved destroying human embryos, a setback for President Barack Obama who had tried to expand research in hopes it would lead to new cures of diseases.

10 Sep 2010

Survey finds women mistreat yeast infections

Few women go through life having never suffered from the uncomfortable symptoms of a yeast infection. In fact, nearly 3 in 4 (72 percent) women will experience their first yeast infection before age 25. Furthermore, the incidence of yeast infections is highest among young women ages 18-24, who are new to the category and uncertain about symptoms and available treatment options.

10 Sep 2010

Shire announces expansion of Human Genetic Therapies pipeline

Shire plc, the global specialty biopharmaceutical company, today announced the expansion of its Human Genetic Therapies pipeline through the exclusive license, in markets outside of North America, for the activin receptor type IIB class of molecules being developed by Acceleron Pharma Inc., a private biotechnology company based in Cambridge, Massachusetts.

10 Sep 2010

Method to predict risk of major coronary event may underestimate risk for millions of Americans: Study

A method that is widely used to predict the risk of a major coronary event may over- or underestimate risk for millions of Americans, according to a study directed by a researcher at the San Francisco VA Medical Center and the University of California, San Francisco.

10 Sep 2010

Candida Force program of detoxification and dietary recommendations effective for weight reduction

Early this month, the cover of First for Women magazine stopped Kathleen Kalaf in her tracks. The magazine featured an article about the connection between systemic Candida, or yeast overgrowth, and fat.

10 Sep 2010

KHN column - Tomorrow's Medicare: The efficient hybrid?

In his latest Kaiser Health News column, Austin Frakt writes: "Since the inception of Medicare, policymakers have wrestled with the problem of how the program can best pay for beneficiaries' medical services. The result of this decades-long struggle has been increasing costs and a Byzantine set of payment methods.

10 Sep 2010

People to gather for CUGH annual conference to discuss critical role of universities in global health

More than 600 people will gather for the Consortium of Universities for Global Health annual conference being held at the University of Washington in Seattle on September 19-21 to discuss the critical role of universities in global health. The conference is the largest university-based global health conference ever held.

10 Sep 2010

FDA approves pediatric use of Protopam Chloride

The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride (pralidoxime chloride), a drug used to treat poisoning by organophosphate pesticides and chemicals (e.g., nerve agents). The drug is approved to be administered either by intravenous (IV) or intramuscular (IM) injections.

10 Sep 2010

Medical News

Meditrina licensor AstraZeneca granted US allowance of patent for endometriosis treatment

SAEC collaborates with Newcastle University for drug induced liver injury research

Overhaul's effect on health spending minimal, government study says

Assessing the needs of disabled Medicare beneficiaries

Translational Research issue focuses field of stem cell research, therapy

PediaWorks, Medikit form PediaCath to develop pediatric catheters

Highlights of 23rd Congress of European College of Neuropsychopharmacology 2010

Study proves brain imaging data can track aberrant brain development

Gates Foundation 2009 annual report released

Avinger initiates enrollment in Wildcat Catheter trial for chronic total occlusions in femoropopliteal lesions

Children with severe, therapy-resistant asthma more likely to have poorer lung function: SARP

Researchers discover generation of pyramidal neurons by glial cell precursors

Obama administration asks appeals court to lift ban on stem cell research funding

Survey finds women mistreat yeast infections

Shire announces expansion of Human Genetic Therapies pipeline

Method to predict risk of major coronary event may underestimate risk for millions of Americans: Study

Candida Force program of detoxification and dietary recommendations effective for weight reduction

KHN column - Tomorrow's Medicare: The efficient hybrid?

People to gather for CUGH annual conference to discuss critical role of universities in global health

FDA approves pediatric use of Protopam Chloride

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News